作者
Mark D Russell, Jon Massey, Edward Roddy, Brian MacKenna, Seb Bacon, Ben Goldacre, Colm D Andrews, George Hickman, Amir Mehrkar, Arti Mahto, Andrew I Rutherford, Samir Patel, Maryam A Adas, Edward Alveyn, Deepak Nagra, Katie Bechman, Joanna M Ledingham, Joanna Hudson, Sam Norton, Andrew P Cope, James B Galloway
发表日期
2023/10/1
期刊
The Lancet Rheumatology
卷号
5
期号
10
页码范围
e622-e632
出版商
Elsevier
简介
Background
Gout is the most prevalent inflammatory arthritis, yet one of the worst managed. Our objective was to assess how the COVID-19 pandemic impacted incidence and quality of care for people with gout in England, UK.
Methods
With the approval of National Health Service England, we did a population-level cohort study using primary care and hospital electronic health record data for 17·9 million adults registered with general practices using TPP health record software, via the OpenSAFELY platform. The study period was from March 1, 2015, to Feb 28, 2023. Individuals aged 18–110 years were defined as having incident gout if they were assigned index diagnostic codes for gout, were registered with TPP practices in England for at least 12 months before diagnosis, did not receive prescriptions for urate-lowering therapy more than 30 days before diagnosis, and had not been admitted to hospital or attended …
学术搜索中的文章
MD Russell, J Massey, E Roddy, B MacKenna… - The Lancet Rheumatology, 2023